In This Section

David T. Teachey, MD
David T. Teachey
Co-Leader, Immune Dysregulation Frontier Program

Dr. Teachey's research focuses on investigating novel therapeutics for children with white blood cell diseases, including ALL and a rare autoimmune disease called Autoimmune Lymphoproliferative Syndrome (ALPS). His research in ALL focuses on studying leukemic cells from children with high-risk disease.



Subscribe to be notified of changes or updates to this page.

16 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Education and Training

BS, Virginia Commonwealth University (Biology), 1993

MD, Eastern Virginia Medical School, 1999

Fellowship, Children's Hospital of Philadelphia (Hematology/Oncology), 2005

Titles and Academic Titles

Co-Leader, Immune Dysregulation Frontier Program

Attending Physician

Associate Professor of Pediatrics

Professional Memberships

American Society of Pediatric Hematology/Oncology, 2003-

American Society of Hematology, 2003-

Children's Oncology Group, 2005-

American Society of Clinical Investigation, 2018-

Professional Awards

Charles E. Culpepper Biomedical Pilot Initiative Award, 2004

Clinical Science Research Award, Children's Hospital of Philadelphia, 2005

Judy S. Finkelstein Memorial Award in Immunology Research, 2005

American Society of Clinical Oncology Young Investigator Award, 2005

American Society of Pediatric Hematology Oncology Young Investigator Award, 2005

United States Immunodeficiency Network Research Award, 2006

American Society of Clinical Oncology Career Development Award, 2006

Larry and Helen Hoag Award in Pediatric Translational Oncology Research, 2007

Lady Barbara Colyton Prize for Autoimmune Research, University of Pennsylvania Award of Excellence, 2010

Golden and Christie Advancement Award for Saving Lives Through Rediscovery Research, 2013

American Cancer Society Research Scholar, 2014

SIOP Basic and Translational Science Research Award, 2018

Publication Highlights

Links of Interest